BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April

Day

• 1
• 2
• 3

• Press Releases

  Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection Will Continue as Planned Following Protocol-Specified Interim Analysis

  April 3, 2026

   · 

  4 min read
• Press Releases

  Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer

  April 3, 2026

   · 

  6 min read
• Press Releases

  Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis

  April 3, 2026

   · 

  2 min read
• Press Releases

  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026

  April 3, 2026

   · 

  2 min read
• Press Releases

  Innate Pharma to Participate in the Kempen Life Sciences Conference

  April 3, 2026

   · 

  2 min read
• Press Releases

  Syneron Bio Announces Completion of $150 Million Series B Financing

  April 3, 2026

   · 

  1 min read
• Press Releases

  Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026

  April 3, 2026

   · 

  4 min read
• Press Releases

  MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026

  April 3, 2026

   · 

  4 min read
• Press Releases

  Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 3, 2026

  April 3, 2026

   · 

  2 min read
• Press Releases

  MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 3, 2026

  April 3, 2026

   · 

  2 min read